Nolotil (Metamizole Magnesium)

Metamizole magnesium works by inhibiting cyclooxygenase enzymes, which leads to a decrease in prostaglandin production. Lower prostaglandin levels reduce pain signal transmission and lower the hypothalamic set‑point for body temperature, providing both analgesic and antipyretic effects.

The prescribing physician determines the appropriate dose of Nolotil based on the individual’s clinical condition, severity of pain or fever, age, weight, and any comorbidities. Dosage regimens are tailored to each patient and should follow the prescriber’s instructions.

Safety data for metamizole magnesium in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and under medical supervision.

To place an order, submit an enquiry on the Nolotil product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with non‑steroidal anti‑inflammatory drugs (NSAIDs), Nolotil offers potent analgesia with less gastric irritation but carries a higher risk of blood‑related adverse events. Unlike opioids, it does not cause respiratory depression, making it a useful alternative for certain acute pain scenarios.

Nolotil should be stored below 25 °C in a dry environment. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure that the container is tightly closed to maintain stability.

Nolotil is administered orally. The tablets or capsules are taken with a full glass of water, preferably after a meal to reduce gastrointestinal discomfort. The exact route and timing should follow the prescribing clinician’s directions.

The most serious risks include agranulocytosis and other severe blood dyscrasias, which can lead to life‑threatening infections. Patients should be monitored for signs of infection, unexplained fever, or unusual bleeding, and immediate medical attention is required if such symptoms appear.

Nolotil should be avoided in individuals with known hypersensitivity to metamizole, those with existing severe bone‑marrow suppression, children under three years of age, and patients for whom the risk of agranulocytosis outweighs the therapeutic benefit. Caution is also advised in pregnant or lactating women.